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Monday, March 2, 2009 371athe four important S4 arginine residues on the voltage-sensing paddle is still un-
known, with some models placing them in an aqueous crevice, and others a lipid
environment. To learn more about the intricate role of lipid in the structure and
function of potassium channels we have studied deuterium and phosphate
ESEEM on spin-labeled, liposome reconstituted KcsA. By scanning the
trans-membrane helices of KcsA, we show that deuterium coupling can be
used to determine residue depth within a lipid bilayer. In addition, residues
that interact with the phosphate head-groups of the lipid can be determined
by phosphate coupling, and their precise location modeled.
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Sarcomeric mutations in MyBPC that cause hypertrophic cardiomyopathy
(HCM) may act as dominant negative alleles by encoding ‘poison polypepti-
des’or as null alleles resulting in haploinsufficiency. To resolve this we have
studied left ventricular muscle samples from patients undergoing surgical
myectomy for obstructive HCM and compared these with samples from non-
failing (donor) heart muscle. Seven out of 27 myectomy samples were found
to contain mutations in MyBP-C: two previously described missense alleles
(Glu258Lys, Arg502Trp) and five premature terminations (truncating in do-
mains C3, C5, C7 [x2], C10). Western blots were performed using an antibody
shown to recognise specifically the N-terminal region (C0-C2) of MyBPC.
MyBPC content was quantified by ELC and densitometry and normalised to
staining with an anti-actin antibody.
No truncated peptides were detected in whole muscle homogenates, or the
myofibrillar fraction, of HCM tissue (including in overloaded gels). However,
the overall level of MyBP-C in myofibrils was reduced by 2454% in myofi-
brils from tissue containing a MyBP-C mutation: 0.76þ/-0.04 (n¼39) vs
1.00þ/-0.05 in non-failing (n¼19)* and 1.01þ/-0.05 (n¼24) in non-MyBPC
mutant myectomies. *p¼0.0005. Four of the myectomy samples individually
showed statistically significant differences from the non-failing group; these
included both truncation and missense samples.
The absence of detectable lower molecular weight protein suggests that the
truncated MyBPC proteins are degraded, arguing against their incorporation
in the myofibre and any dominant negative effect. In contrast, the lowered rel-
ative level of full length MyBPC in the myofibre argues strongly for haploin-
sufficiency as the disease mechanism (potentially for missense as well as trun-
cation alleles). Previous work on partial extraction of MyBPC suggests that
lowered MyBPC stoichiometry would be expected to alter muscle function.
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Cardiac TnT variants with abnormal splicing in the N-terminal region have
been found in avian and mammalian cases of dilated cardiomyopathy. Similar
abnormality also occurs in myopathic and failing human hearts. These cardiac
TnT variants may play a role in the pathogenesis and pathophysiology of car-
diomyopathy and heart failure. Without losses of function, the cardiac TnT var-
iants result in only minor differences in thin filament Ca2þ sensitivity. There-
fore, we hypothesize that the heterogeneity resulting from the presence of twoor more functionally distinct cardiac TnT variants in the normally uniform
adult cardiac muscle thin filaments desynchronizes myofilament activation
and decreases the contractile efficiency. We studied transgenic mouse hearts
expressing one or two of the myopathy-related cardiac TnT variants together
with the wild type adult cardiac TnT. The function of isolated working hearts
was examined for pumping efficiency in the absence of neurohumoral influ-
ence. The results showed that at heart rate of 480 beat per minute and pressure
load of 90 mmHg, contractile and relaxation velocities were lower in the trans-
genic mouse hearts than that in the wild type hearts. Left ventricular pumping
efficiency calculated by the ratio of ejection integral to total systolic integral
was also lower in the transgenic mouse hearts than that in wild type controls.
When stressed by pacing at 600 beats per minute and giving 10 nM isoproter-
enol, the transgenic mouse hearts exhibited shorter ejection time and decreased
cardiac efficiency than that of wild type hearts. These results indicate a chronic
pathogenic mechanism that TnT heterogeneity leads to decreased myocardial
efficiency due to desynchronized responses to intracellular Ca2þ transient.
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Cardiac myosin binding protein-C (cMyBP-C), long known to interact with
thick filaments, also interacts with thin filaments (actin) through its N-terminus.
However, a single actin binding site has not been identified and it is unclear
whether one or more N-terminal domains of cMyBP-C interact with actin. In
this study we aimed to characterize the interaction of the N-terminus of
cMyBP-C with actin using recombinant proteins consisting of various
cMyBP-C N-terminal domains. Results from high speed cosedimentation bind-
ing assays showed that recombinant proteins containing the C1 domain and the
MyBP-C motif bound to F-actin at a 1:1 molar ratio with a dissociation constant
(Kd) ~ 10 uM. In contrast, proteins containing either C1 or the motif showed
reduced binding at a 1:2 molar ratio. Proteins containing both C1 and the motif
also bundled actin filaments, suggesting multiple actin interaction sites. Bind-
ing of recombinant proteins to Ca2þ regulated thin filaments was similar to
binding to F-actin alone. Strongly bound myosin cross-bridges (myosin S1,
no ATP) abolished cMyBP-C binding to actin, while weakly bound cross-
bridges (myosin S1 plus ATP) diminished, but did not abolish, binding. Re-
combinant myosin DS2, which binds to the MyBP-C motif in vitro (~6 uM),
did not affect cMyBP-C binding to actin. However, phosphorylation of the mo-
tif or alkaline pH both reduced binding. Together, these results suggest that the
N-terminus of cMyBP-C contains at least two binding sites for actin and that
binding is modulated through electrostatic interactions. Supported by NIH
HL080367 to SPH and a NSF Graduate Research Fellowship to JFS.
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Background Mutations in the MYBPC3 gene, encoding for cardiac myosin
binding protein C (cMyBP-C), are a frequent cause of familial hypertrophic
cardiomyopathy (FHCM). In the present study we investigated if protein com-
position and function of the sarcomere are altered in a homogenous FHCM pa-
tient group with truncating mutations in MYBPC3 (MYBPC3mut).
Methods and Results Comparisons were made between cardiac samples from
MYBPC3 mutant carriers (c.2373dupG, n¼7; c.2864_2865delCT, n¼4) and
non-failing donors (n¼8). Western Immunoblotting using antibodies directed
against different parts of cMyBP-C did not reveal truncated cMyBP-C in
MYBPC3mut. Protein expression of cMyBP-C was significantly reduced in
MYBPC3mut by 3355%. Cardiac MyBP-C phosphorylation in MYBPC3mut
samples was similar to the values in donor samples, whereas the phosphoryla-
tion status of troponin I (cTnI) was reduced by 8455%, indicating divergent
phosphorylation of the two main contractile target proteins of the beta-adrener-
gic pathway. Force measurements in mechanically isolated Triton-per-
meabilized cardiomyocytes demonstrated a decrease in maximal force per
cross-sectional area of the myocytes in MYBPC3mut (21.453.9 kN/m
2) com-
pared to donor (34.551.7 kN/m2). Moreover, Ca2þ-sensititivy was higher
in MYBPC3mut (pCa50¼5.6050.04) than in donor (pCa50¼5.5250.03), con-
sistent with reduced cTnI phosphorylation. Treatment with exogenous protein
kinase A, to mimic beta-adrenergic stimulation, did not correct reduced
